Artigos de revistas sobre o tema "Inhibitory factor 1"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Inhibitory factor 1".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Shi, Qizhen, Erin L. Kuether, Jocelyn A. Schroeder, Crystal L. Perry, Scot A. Fahs e Robert R. Montgomery. "Factor VIII Inhibitors: Von Willebrand Factor Makes A Difference In Vitro and In Vivo". Blood 116, n.º 21 (19 de novembro de 2010): 709. http://dx.doi.org/10.1182/blood.v116.21.709.709.
Texto completo da fonteKreisberg, R., M. S. Detrick, A. P. Osmand e R. N. Moore. "Cytokine mediation of the suppressive effect of ferritin on colony-stimulating factor-1-dependent monocytopoiesis." Journal of Immunology 150, n.º 11 (1 de junho de 1993): 5094–103. http://dx.doi.org/10.4049/jimmunol.150.11.5094.
Texto completo da fonteMihelič, Marko, e Dušan Turk. "Two decades of thyroglobulin type-1 domain research". Biological Chemistry 388, n.º 11 (1 de novembro de 2007): 1123–30. http://dx.doi.org/10.1515/bc.2007.155.
Texto completo da fonteBuzzelli, Mark D., Murali Nagarajan, John F. Radtka, Margaret L. Shumate, Maithili Navaratnarajah, Charles H. Lang e Robert N. Cooney. "Nuclear Factor-κB Mediates the Inhibitory Effects of Tumor Necrosis Factor-α on Growth Hormone-Inducible Gene Expression in Liver". Endocrinology 149, n.º 12 (21 de agosto de 2008): 6378–88. http://dx.doi.org/10.1210/en.2007-1574.
Texto completo da fontePehlivan, Melek, Ceyda Caliskan, Zeynep Yuce e Hakkı Ogun Sercan. "Forced expression of Wnt antagonists sFRP1 and WIF1 sensitizes chronic myeloid leukemia cells to tyrosine kinase inhibitors". Tumor Biology 39, n.º 5 (maio de 2017): 101042831770165. http://dx.doi.org/10.1177/1010428317701654.
Texto completo da fonteZozulya, N. I., V. M. Chernov, I. S. Tarasova e A. G. Rumyantsev. "Unsolved issues of providing medical care to patients with hemophilia with inhibitors in Russia". Russian Journal of Pediatric Hematology and Oncology 6, n.º 2 (24 de abril de 2019): 48–53. http://dx.doi.org/10.21682/2311-1267-2019-6-2-48-53.
Texto completo da fonteE, Jingwen, Ye Liu, Shanshan Guan, Zhijian Luo, Fei Han, Weiwei Han, Song Wang e Hao Zhang. "How Different Substitution Positions of F, Cl Atoms in Benzene Ring of 5-Methylpyrimidine Pyridine Derivatives Affect the Inhibition Ability of EGFRL858R/T790M/C797S Inhibitors: A Molecular Dynamics Simulation Study". Molecules 25, n.º 4 (18 de fevereiro de 2020): 895. http://dx.doi.org/10.3390/molecules25040895.
Texto completo da fonteBatsuli, Glaivy, Courtney Cox, John F. Healey, Pete Lollar e Shannon L. Meeks. "Anti-Factor VIII C1 Domain Antibodies Are Present in the Plasmas of Patients with Hemophilia and Inhibitors". Blood 124, n.º 21 (6 de dezembro de 2014): 1482. http://dx.doi.org/10.1182/blood.v124.21.1482.1482.
Texto completo da fonteKawai, Misato, Tomohiro Osanai, Makoto Tanaka, Koji Magota, Hirofumi Tomita e Ken Okumura. "Mitochondrial Inhibitory Factor Protein 1 Functions as an Endogenous Inhibitor for Coupling Factor 6". Journal of Cellular Biochemistry 117, n.º 7 (15 de janeiro de 2016): 1680–87. http://dx.doi.org/10.1002/jcb.25461.
Texto completo da fonteTenan, Mirna, Giulia Fulci, Michele Albertoni, Annie-Claire Diserens, Marie-France Hamou, Michèle El Atifi-Borel, Jean-Jacques Feige, Michael S. Pepper e Erwin G. Van Meir. "Thrombospondin-1 Is Downregulated by Anoxia and Suppresses Tumorigenicity of Human Glioblastoma Cells". Journal of Experimental Medicine 191, n.º 10 (15 de maio de 2000): 1789–98. http://dx.doi.org/10.1084/jem.191.10.1789.
Texto completo da fonteNa, Bon Hyang, Thi Xoan Hoang e Jae Young Kim. "Hsp90 Inhibition Reduces TLR5 Surface Expression and NF-κB Activation in Human Myeloid Leukemia THP-1 Cells". BioMed Research International 2018 (2018): 1–8. http://dx.doi.org/10.1155/2018/4319369.
Texto completo da fonteSen, Prosenjit, Andrey Komissarov, Usha R. Pendurthi, Steven Idell e L. Vijaya Mohan Rao. "Plasminogen Activator Inhibitor-1 Inhibits Factor VIIa Bound to Tissue Factor". Blood 112, n.º 11 (16 de novembro de 2008): 1023. http://dx.doi.org/10.1182/blood.v112.11.1023.1023.
Texto completo da fonteBilan, Philip J., Jonathan B. Weitzman, Tracey Pflieger, C. Roy D. Lancaster, Alan Stafford e Richard M. Epand. "Potent inhibitors of glucagon-stimulated adenylate cyclase associated with serum lipoprotein particles". Biochemistry and Cell Biology 67, n.º 11-12 (1 de novembro de 1989): 759–62. http://dx.doi.org/10.1139/o89-114.
Texto completo da fonteAhamed, Jasimuddin, Mattias Belting e Wolfram Ruf. "Regulation of tissue factor–induced signaling by endogenous and recombinant tissue factor pathway inhibitor 1". Blood 105, n.º 6 (15 de março de 2005): 2384–91. http://dx.doi.org/10.1182/blood-2004-09-3422.
Texto completo da fonteDimitrov, Jordan D., Suryasarathi Dasgupta, Ana-Maria Navarrete, Sandrine Delignat, Yohann Repesse, Yann Meslier, Cyril Planchais et al. "Induction of heme oxygenase-1 in factor VIII–deficient mice reduces the immune response to therapeutic factor VIII". Blood 115, n.º 13 (1 de abril de 2010): 2682–85. http://dx.doi.org/10.1182/blood-2009-04-216408.
Texto completo da fonteMeeks, Shannon, John F. Healey, Ernest T. Parker, Rachel T. Barrow e John (Pete) Lollar. "Non-Classical Anti-Factor VIII C2 Domain Antibodies Are Pathogenic in a Murine in Vivo Bleeding Model." Blood 112, n.º 11 (16 de novembro de 2008): 2027. http://dx.doi.org/10.1182/blood.v112.11.2027.2027.
Texto completo da fonteDubois, C. M., F. W. Ruscetti, E. W. Palaszynski, L. A. Falk, J. J. Oppenheim e J. R. Keller. "Transforming growth factor beta is a potent inhibitor of interleukin 1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action." Journal of Experimental Medicine 172, n.º 3 (1 de setembro de 1990): 737–44. http://dx.doi.org/10.1084/jem.172.3.737.
Texto completo da fonteTiku, K., M. L. Tiku, S. Liu e J. L. Skosey. "Normal human neutrophils are a source of a specific interleukin 1 inhibitor." Journal of Immunology 136, n.º 10 (15 de maio de 1986): 3686–92. http://dx.doi.org/10.4049/jimmunol.136.10.3686.
Texto completo da fonteAhamed, Jasimuddin, Mattias Belting e Wolfram Ruf. "Regulation of Tissue Factor Signaling by Tissue Factor Pathway Inhibitor." Blood 104, n.º 11 (16 de novembro de 2004): 1930. http://dx.doi.org/10.1182/blood.v104.11.1930.1930.
Texto completo da fonteTang, Liang, Clark Pan, Harpartap Atwal, Jennifer Nixon, Thomas Barnett, John E. Murphy, Baisong Mei e Michael Fournel. "PEGylation of Factor VIII Reduces the Inhibitory Effects of Human Antibody Inhibitors on the Factor VIII Molecule." Blood 108, n.º 11 (16 de novembro de 2006): 4017. http://dx.doi.org/10.1182/blood.v108.11.4017.4017.
Texto completo da fonteHe, Enqi, Wei Quan, Jie Luo, Chuxin Liu, Wanting Zheng e Qingwu Shen. "Absorption and Transport Mechanism of Red Meat-Derived N-glycolylneuraminic Acid and Its Damage to Intestinal Barrier Function through the NF-κB Signaling Pathway". Toxins 15, n.º 2 (6 de fevereiro de 2023): 132. http://dx.doi.org/10.3390/toxins15020132.
Texto completo da fonteDahiya, Raivir. "PP-543 The Functional Significance of Wnt Inhibitory Factor-1 (WIF-1) Gene in Kidney Cancer". Japanese Journal of Urology 101, n.º 2 (2010): 504. http://dx.doi.org/10.5980/jpnjurol.101.504_3.
Texto completo da fonteYada, Koji, Keiji Nogami, Kenichi Ogiwara, Katsumi Nishiya, Masahiro Takeyama e Midori Shim. "Effects of Anti-FVIII Inhibitors On Factor VIIa/Tissue Factor-Catalyzed Activation and Inactivation of Factor VIII." Blood 114, n.º 22 (20 de novembro de 2009): 3169. http://dx.doi.org/10.1182/blood.v114.22.3169.3169.
Texto completo da fonteSun, Xuemei, Judith E. Layton, Andrew Elefanty e Graham J. Lieschke. "Comparison of effects of the tyrosine kinase inhibitors AG957, AG490, and STI571 on BCR-ABL–expressing cells, demonstrating synergy between AG490 and STI571". Blood 97, n.º 7 (1 de abril de 2001): 2008–15. http://dx.doi.org/10.1182/blood.v97.7.2008.
Texto completo da fonteNegrier, Claude, Shannon L. Meeks, Johannes Oldenburg, Uri Martinowitz, Jean-Claude Bordet, Bernd Poetzsch, Raed Al Dieri et al. "Recombinant Porcine Factor VIII Corrects Thrombin Generation and Improves Clot Structure In Vitro in Plasma Containing Anti-Factor VIII Inhibitory Antibodies". Blood 118, n.º 21 (18 de novembro de 2011): 2282. http://dx.doi.org/10.1182/blood.v118.21.2282.2282.
Texto completo da fonteEubanks, Joshua, Wallace Hunter Baldwin, Rebecca Markovitz, Ernest T. Parker e Shannon L. Meeks. "Anti-Factor VIII A2 Epitopes In a Murine Bleeding Model". Blood 122, n.º 21 (15 de novembro de 2013): 1100. http://dx.doi.org/10.1182/blood.v122.21.1100.1100.
Texto completo da fonteKurisaki, Keiko, Akira Kurisaki, Ulrich Valcourt, Alexei A. Terentiev, Katerina Pardali, Peter ten Dijke, Carl-Henrik Heldin, Johan Ericsson e Aristidis Moustakas. "Nuclear Factor YY1 Inhibits Transforming Growth Factor β- and Bone Morphogenetic Protein-Induced Cell Differentiation". Molecular and Cellular Biology 23, n.º 13 (1 de julho de 2003): 4494–510. http://dx.doi.org/10.1128/mcb.23.13.4494-4510.2003.
Texto completo da fonteVernallis, Ann B., Keith R. Hudson e John K. Heath. "An Antagonist for the Leukemia Inhibitory Factor Receptor Inhibits Leukemia Inhibitory Factor, Cardiotrophin-1, Ciliary Neurotrophic Factor, and Oncostatin M". Journal of Biological Chemistry 272, n.º 43 (24 de outubro de 1997): 26947–52. http://dx.doi.org/10.1074/jbc.272.43.26947.
Texto completo da fonteChow, Tan Wei, Ming Thong Ong e Shaharum Shamsuddin. "WNT inhibitory factor-1 (WIF-1): A new role in carcinogenesis?" Journal of Clinical Oncology 32, n.º 15_suppl (20 de maio de 2014): 11124. http://dx.doi.org/10.1200/jco.2014.32.15_suppl.11124.
Texto completo da fonteCamussi, G., C. Tetta, F. Bussolino e C. Baglioni. "Synthesis and release of platelet-activating factor is inhibited by plasma alpha 1-proteinase inhibitor or alpha 1-antichymotrypsin and is stimulated by proteinases." Journal of Experimental Medicine 168, n.º 4 (1 de outubro de 1988): 1293–306. http://dx.doi.org/10.1084/jem.168.4.1293.
Texto completo da fonteOsanai, Tomohiro, Makoto Tanaka, Kasumi Mikami, Maiko Kitajima, Koji Magota, Hirofumi Tomita e Ken Okumura. "Mitochondrial inhibitory factor protein 1 attenuates coupling factor 6‐induced aging signal". Journal of Cellular Biochemistry 119, n.º 7 (25 de março de 2018): 6194–203. http://dx.doi.org/10.1002/jcb.26828.
Texto completo da fonteZaichuk, Tetiana A., Emelyn H. Shroff, Rebekah Emmanuel, Stephanie Filleur, Thomas Nelius e Olga V. Volpert. "Nuclear Factor of Activated T Cells Balances Angiogenesis Activation and Inhibition". Journal of Experimental Medicine 199, n.º 11 (7 de junho de 2004): 1513–22. http://dx.doi.org/10.1084/jem.20040474.
Texto completo da fonteLee, Min-Jung, Eun-Jung Kim, Liwen Li e Han-Sung Jung. "Roles of Wnt inhibitory factor 1 during tooth morphogenesis". Cell and Tissue Research 362, n.º 1 (18 de abril de 2015): 61–68. http://dx.doi.org/10.1007/s00441-015-2170-3.
Texto completo da fonteNAKAMARU, Y. "Macrophage migration inhibitory factor (MIF) in allergic rhinitis*1". Journal of Allergy and Clinical Immunology 113, n.º 2 (fevereiro de 2004): S245. http://dx.doi.org/10.1016/j.jaci.2004.01.346.
Texto completo da fonteChimeo, Cindy, Analia Veronica Fernandez-Gimenez, Michelangelo Campanella, Ofelia Mendez-Romero e Adriana Muhlia-Almazan. "The shrimp mitochondrial FoF1-ATPase inhibitory factor 1 (IF1)". Journal of Bioenergetics and Biomembranes 47, n.º 5 (25 de agosto de 2015): 383–93. http://dx.doi.org/10.1007/s10863-015-9621-0.
Texto completo da fonteThung, E. G., J. Chou, L. You, Z. Xu e D. M. Jablons. "Hypermethylation Silences Wnt Inhibitory Factor 1 in Nasopharyngeal Carcinoma". Journal of Investigative Medicine 54, n.º 1_suppl (janeiro de 2006): 104–5. http://dx.doi.org/10.1177/108155890605401s28.
Texto completo da fonteKazama, Yoshiaki. "The Importance of the Binding of Factor Xa to Phospholipids in the Inhibitory Mechanism of Tissue Factor Pathway Inhibitor: The Transmembrane and Cytoplasmic Domains of Tissue Factor Are not Essential for the Inhibitory Action of Tissue Factor Pathway Inhibitor". Thrombosis and Haemostasis 77, n.º 03 (1997): 492–97. http://dx.doi.org/10.1055/s-0038-1655995.
Texto completo da fonteFedorczyk, Bartlomiej, Piotr F. J. Lipiński, Anna K. Puszko, Dagmara Tymecka, Beata Wilenska, Wioleta Dudka, Gerard Y. Perret, Rafal Wieczorek e Aleksandra Misicka. "Triazolopeptides Inhibiting the Interaction between Neuropilin-1 and Vascular Endothelial Growth Factor-165". Molecules 24, n.º 9 (6 de maio de 2019): 1756. http://dx.doi.org/10.3390/molecules24091756.
Texto completo da fonteSeckinger, P., K. Williamson, J. F. Balavoine, B. Mach, G. Mazzei, A. Shaw e J. M. Dayer. "A urine inhibitor of interleukin 1 activity affects both interleukin 1 alpha and 1 beta but not tumor necrosis factor alpha." Journal of Immunology 139, n.º 5 (1 de setembro de 1987): 1541–45. http://dx.doi.org/10.4049/jimmunol.139.5.1541.
Texto completo da fontePlantier, Jean-Luc, Didier Saboulard, Marc Delcourt, Nathalie Enjolras e Claude Negrier. "Substitution of Four Residues Revealed by High-Throughput Screening of Human Factor VIII A2 Domain Generated a Recombinant Molecule That Escapes to Anti-Factor VIII Antibodies". Blood 112, n.º 11 (16 de novembro de 2008): 3067. http://dx.doi.org/10.1182/blood.v112.11.3067.3067.
Texto completo da fonteMetcalf, D. "The Unsolved Enigmas of Leukemia Inhibitory Factor". Stem Cells 21, n.º 1 (1 de janeiro de 2003): 5–14. http://dx.doi.org/10.1634/stemcells.21-1-5.
Texto completo da fonteAl-Salem, Huda S., Md Arifuzzaman, Iman S. Issa e A. F. M. Motiur Rahman. "Isatin-Hydrazones with Multiple Receptor Tyrosine Kinases (RTKs) Inhibitory Activity and In-Silico Binding Mechanism". Applied Sciences 11, n.º 9 (21 de abril de 2021): 3746. http://dx.doi.org/10.3390/app11093746.
Texto completo da fonteChen, Cheng-Yu, Guo-Yuan Zhu, Jing-Rong Wang e Zhi-Hong Jiang. "Phenanthroindolizidine alkaloids from Tylophora atrofolliculata with hypoxia-inducible factor-1 (HIF-1) inhibitory activity". RSC Advances 6, n.º 83 (2016): 79958–67. http://dx.doi.org/10.1039/c6ra16455b.
Texto completo da fonteShi, Jialan, e Gary E. Gilbert. "Lactadherin inhibits enzyme complexes of blood coagulation by competing for phospholipid-binding sites". Blood 101, n.º 7 (1 de abril de 2003): 2628–36. http://dx.doi.org/10.1182/blood-2002-07-1951.
Texto completo da fonteMorishita, Hideaki, Toru Yamakawa, Tomokazu Matsusue, Takeshi Kusuyama, Rie Sameshima-Aruga, Jiro Hirose, Atsushi Nii et al. "Novel factor Xa and plasma kallikrein inhibitory-activities of the second Kunitz-type inhibitory domain of urinary trypsin inhibitor". Thrombosis Research 73, n.º 3-4 (fevereiro de 1994): 193–204. http://dx.doi.org/10.1016/0049-3848(94)90098-1.
Texto completo da fonteLicchesi, J. D. F., L. Van Neste, V. K. Tiwari, L. Cope, X. Lin, S. B. Baylin e J. G. Herman. "Transcriptional regulation of Wnt inhibitory factor-1 by Miz-1/c-Myc". Oncogene 29, n.º 44 (9 de agosto de 2010): 5923–34. http://dx.doi.org/10.1038/onc.2010.322.
Texto completo da fonteChim, C. S., T. K. Fung, K. F. Wong, J. S. Lau e R. Liang. "Infrequent Wnt inhibitory factor-1 (Wif-1) methylation in chronic lymphocytic leukemia". Leukemia Research 30, n.º 9 (setembro de 2006): 1135–39. http://dx.doi.org/10.1016/j.leukres.2005.12.005.
Texto completo da fonteCornish, J., K. E. Callon, S. G. E. Edgar e I. R. Reid. "Leukaemia inhibitory factor is mitogenic to osteoblasts". Bone 17, n.º 6 (dezembro de 1995): 561. http://dx.doi.org/10.1016/8756-3282(96)87802-1.
Texto completo da fonteOlsson, Lina, Gudrun Lindmark, Marie-Louise Hammarström, Sten Hammarström e Basel Sitohy. "Evaluating macrophage migration inhibitory factor 1 expression as a prognostic biomarker in colon cancer". Tumor Biology 42, n.º 6 (junho de 2020): 101042832092452. http://dx.doi.org/10.1177/1010428320924524.
Texto completo da fonteHuang, Jing, Rui Tian, Yongqiang Yang, Rong Jiang, Jie Dai, Li Tang e Li Zhang. "The SIRT1 inhibitor EX-527 suppresses mTOR activation and alleviates acute lung injury in mice with endotoxiemia". Innate Immunity 23, n.º 8 (27 de setembro de 2017): 678–86. http://dx.doi.org/10.1177/1753425917733531.
Texto completo da fonte